发明名称 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES
摘要 Compounds of formula (I), wherein Y is O or S, Ar is an aryl group or a heteroaryl group, R is H, an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, or -C(O)R1, wherein R1 is hydrogen, an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, or NR2R3 wherein R2 and R3 independently are hydrogen, an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, or a heteroaryl group, and X is -NH-OH or -OH. Pharmaceutically acceptable prodrugs, salts and solvates of these compounds. Methods of inhibiting the activity of metalloproteinases by administering a compound of the formula (I) or a prodrug, salt of solvate thereof. Pharmaceutical compositions comprising an effective amount of these compounds, prodrugs, salts, and solvates.
申请公布号 CA2285372(A1) 申请公布日期 1998.10.08
申请号 CA19982285372 申请日期 1998.03.31
申请人 AGOURON PHARMACEUTICALS, INC. 发明人 BENDER, STEVEN L.;ABREO, MELWYN A.
分类号 A61K31/18;A61K31/198;A61K31/216;A61K31/4164;A61K31/42;A61K31/4406;A61K31/4409;A61K31/443;A61K31/4439;A61P1/02;A61P9/10;A61P13/00;A61P17/00;A61P19/02;A61P19/10;A61P25/28;A61P27/02;A61P29/00;A61P35/00;A61P35/04;A61P43/00;C07C311/29;C07C323/52;C07C323/59;C07C323/60;C07D213/32;C07D213/34;C07D213/64;C07D213/643;C07D213/68;C07D213/70;C07D233/54;C07D261/08;C07D405/12;C07D413/12;(IPC1-7):C07D233/54;C07D261/10;C07D213/12;A61K31/195;A61K31/41;A61K31/44;C07C323/57 主分类号 A61K31/18
代理机构 代理人
主权项
地址